626 related articles for article (PubMed ID: 11520127)
21. Catechol-O-methyltransferase inhibition protects against 3,4-dihydroxyphenylalanine (DOPA) toxicity in primary mesencephalic cultures: new insights into levodopa toxicity.
Blessing H; Bareiss M; Zettlmeisl H; Schwarz J; Storch A
Neurochem Int; 2003 Jan; 42(2):139-51. PubMed ID: 12421594
[TBL] [Abstract][Full Text] [Related]
22. Effects of acute and sub-chronic L-dopa therapy on striatal L-dopa methylation and dopamine oxidation in an MPTP mouse model of Parkinsons disease.
Smith ML; King J; Dent L; Mackey V; Muthian G; Griffin B; Charlton CG
Life Sci; 2014 Aug; 110(1):1-7. PubMed ID: 24880075
[TBL] [Abstract][Full Text] [Related]
23. The effect of prolonged vasopressin administration on the level and metabolism of catecholamines in the rat brain and kidneys.
Szmigielska H
Acta Physiol Pol; 1976; 27(3):259-64. PubMed ID: 7918
[TBL] [Abstract][Full Text] [Related]
24. DNA shuffling of methionine adenosyltransferase gene leads to improved S-adenosyl-L-methionine production in Pichia pastoris.
Hu H; Qian J; Chu J; Wang Y; Zhuang Y; Zhang S
J Biotechnol; 2009 May; 141(3-4):97-103. PubMed ID: 19433211
[TBL] [Abstract][Full Text] [Related]
25. The role of the regulatory enzymes of catecholamine synthesis in Parkinson's disease.
Goldstein M; Lieberman A
Neurology; 1992 Apr; 42(4 Suppl 4):8-12; discussion 41-8. PubMed ID: 1350074
[TBL] [Abstract][Full Text] [Related]
26. Effect of L-Dopa and the catechol-O-methyltransferase inhibitor Ro 41-0960 on sulfur amino acid metabolites in rats.
Miller JW; Shukitt-Hale B; Villalobos-Molina R; Nadeau MR; Selhub J; Joseph JA
Clin Neuropharmacol; 1997 Feb; 20(1):55-66. PubMed ID: 9037574
[TBL] [Abstract][Full Text] [Related]
27. The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease.
Białecka M; Droździk M; Kłodowska-Duda G; Honczarenko K; Gawrońska-Szklarz B; Opala G; Stankiewicz J
Acta Neurol Scand; 2004 Oct; 110(4):260-6. PubMed ID: 15355491
[TBL] [Abstract][Full Text] [Related]
28. CNS dopamine oxidation and catechol-O-methyltransferase: importance in the etiology, pharmacotherapy, and dietary prevention of Parkinson's disease.
Zhu BT
Int J Mol Med; 2004 Mar; 13(3):343-53. PubMed ID: 14767563
[TBL] [Abstract][Full Text] [Related]
29. Crystal structures of human 108V and 108M catechol O-methyltransferase.
Rutherford K; Le Trong I; Stenkamp RE; Parson WW
J Mol Biol; 2008 Jun; 380(1):120-30. PubMed ID: 18486144
[TBL] [Abstract][Full Text] [Related]
30. Distribution of catechol-O-methyltransferase (COMT) proteins and enzymatic activities in wild-type and soluble COMT deficient mice.
Myöhänen TT; Schendzielorz N; Männistö PT
J Neurochem; 2010 Jun; 113(6):1632-43. PubMed ID: 20374420
[TBL] [Abstract][Full Text] [Related]
31. The crystal structure of tetrameric methionine adenosyltransferase from rat liver reveals the methionine-binding site.
González B; Pajares MA; Hermoso JA; Alvarez L; Garrido F; Sufrin JR; Sanz-Aparicio J
J Mol Biol; 2000 Jul; 300(2):363-75. PubMed ID: 10873471
[TBL] [Abstract][Full Text] [Related]
32. The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications.
Bialecka M; Kurzawski M; Klodowska-Duda G; Opala G; Tan EK; Drozdzik M
Pharmacogenet Genomics; 2008 Sep; 18(9):815-21. PubMed ID: 18698234
[TBL] [Abstract][Full Text] [Related]
33. The effect of subchronic, intermittent L-DOPA treatment on neuronal nitric oxide synthase and soluble guanylyl cyclase expression and activity in the striatum and midbrain of normal and MPTP-treated mice.
Chalimoniuk M; Langfort J
Neurochem Int; 2007 May; 50(6):821-33. PubMed ID: 17379358
[TBL] [Abstract][Full Text] [Related]
34. Biochemistry and pharmacology of catechol-O-methyltransferase inhibitors.
Nissinen E; Männistö PT
Int Rev Neurobiol; 2010; 95():73-118. PubMed ID: 21095460
[TBL] [Abstract][Full Text] [Related]
35. Delayed O-methylation of l-DOPA in MB-COMT-deficient mice after oral administration of l-DOPA and carbidopa.
Tammimäki A; Aonurm-Helm A; Männistö PT
Xenobiotica; 2018 Apr; 48(4):325-331. PubMed ID: 28375049
[TBL] [Abstract][Full Text] [Related]
36. Enzymatic methylation of microsomal metabolites of benzo(a)pyrene.
Lombardi PE; Mayhew JW; Goldin BR; Gregory ME; Lynch MA; Sullivan CE; Gorbach SL
Cancer Res; 1981 Nov; 41(11 Pt 1):4415-9. PubMed ID: 6272977
[TBL] [Abstract][Full Text] [Related]
37. Sex-dependent compensated oxidative stress in the mouse liver upon deletion of catechol O-methyltransferase.
Tenorio-Laranga J; Männistö PT; Karayiorgou M; Gogos JA; García-Horsman JA
Biochem Pharmacol; 2009 May; 77(9):1541-52. PubMed ID: 19426692
[TBL] [Abstract][Full Text] [Related]
38. Suppression of catechol-O-methyltransferase activity through blunting of alpha2-adrenoceptor can explain hypertension in Dahl salt-sensitive rats.
Hirano Y; Tsunoda M; Shimosawa T; Matsui H; Fujita T; Funatsu T
Hypertens Res; 2007 Mar; 30(3):269-78. PubMed ID: 17510509
[TBL] [Abstract][Full Text] [Related]
39. Effect of dopamine uptake inhibition on brain catecholamine levels and locomotion in catechol-O-methyltransferase-disrupted mice.
Huotari M; Santha M; Lucas LR; Karayiorgou M; Gogos JA; Männistö PT
J Pharmacol Exp Ther; 2002 Dec; 303(3):1309-16. PubMed ID: 12438556
[TBL] [Abstract][Full Text] [Related]
40. On the role of O-methylation in the metabolism of S-adenosylmethionine in rat brain.
Waldmeier PC; Feldtrauer JJ
Biochem Pharmacol; 1987 Sep; 36(17):2855-61. PubMed ID: 3632711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
